Abstract | PURPOSE: The clinical significance of proteinase-3-antineutrophil cytoplasmic antibody (PR3-ANCA) positivity is not well established in idiopathic interstitial pneumonia (IIP) patients. We aimed to determine the clinical features of PR3-ANCA-positive IIP patients. METHODS: RESULTS: Sixteen patients (4.4 %) were PR3-ANCA-positive IIP and 94 (26 %) were ANCA-negative IPF. The median age at diagnosis (72 vs. 70 years, P = 0.17) and proportion of males (75 vs. 89 %, P = 0.12) in PR3-ANCA-positive IIP and ANCA-negative IPF patients, respectively, were not significantly different. Radiologically, the HRCT patterns of PR3-ANCA-positive IIP patients varied (UIP, n = 3, 18.8 %; possible UIP, n = 3, 18.8 %; NSIP, n = 5, 31.3 %; unclassifiable CT pattern, n = 5, 31.3 %) more than those of ANCA-negative IPF patients (UIP, n = 69, 73.4 %; possible UIP, n = 25, 26.6 %; P < 0.001). No PR3-ANCA-positive IIP patients developed ANCA-associated vasculitis. The 5-year survival rate was 50 % in PR3-ANCA-positive IIP patients and 52 % in ANCA-negative IPF patients with no significant difference (P = 0.96 by log-rank test). CONCLUSIONS: The HRCT patterns of PR3-ANCA-positive IIP patients varied more than those of the IPF patients, but the clinical features of high IIP-onset age and male predominance were similar between the groups. Furthermore, PR3-ANCA-positive IIP patients had a poor prognosis similar to that of IPF patients.
|
Authors | Hironao Hozumi, Noriyuki Enomoto, Yoshiyuki Oyama, Masato Kono, Tomoyuki Fujisawa, Naoki Inui, Yutaro Nakamura, Takafumi Suda |
Journal | Lung
(Lung)
Vol. 194
Issue 2
Pg. 235-42
(Apr 2016)
ISSN: 1432-1750 [Electronic] United States |
PMID | 26873743
(Publication Type: Journal Article)
|
Chemical References |
- Antibodies, Antineutrophil Cytoplasmic
- Biomarkers
- Myeloblastin
|
Topics |
- Aged
- Aged, 80 and over
- Antibodies, Antineutrophil Cytoplasmic
(blood)
- Biomarkers
(blood)
- Biopsy
- Enzyme-Linked Immunosorbent Assay
- Female
- Humans
- Idiopathic Interstitial Pneumonias
(blood, diagnosis, immunology, mortality)
- Kaplan-Meier Estimate
- Lung
(diagnostic imaging, pathology)
- Male
- Middle Aged
- Myeloblastin
(immunology)
- Prognosis
- Retrospective Studies
- Time Factors
- Tomography, X-Ray Computed
|